Marker Therapeutics
MRKR
MRKR
6 hedge funds and large institutions have $163K invested in Marker Therapeutics in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$54K |
| 2 |
Goldman Sachs
New York
|
+$48K |
| 3 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
+$10K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$61.6K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$23K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VKH
1
Virtu KCG Holdings
New York
| $54K | +$54K | +1,211 | New |
|
|
2
Millennium Management
New York
| $50K | -$61.6K | -1,358 | -55% |
|
|
3
Goldman Sachs
New York
| $48K | +$48K | +1,059 | New |
|
|
NSIM
4
North Star Investment Management
Chicago,
Illinois
| $10K | +$10K | +223 | New |
|
|
AG
5
Advisor Group
Phoenix,
Arizona
| $1K | – | – | – |
|
|
PAM
6
Panagora Asset Management
Boston,
Massachusetts
| – | -$23K | -678 | Closed |
|